Vessey Rupert's Form 4 filing
Bristol Myers Squibb Co (BMY) · filed Dec 17, 2021
- Accession no.
- 0000014272-21-000234
- Filed
- Dec 17, 2021
- Trade date
- Dec 16, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.20M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vessey RupertCIK 0001677618 | Officer (EVP, Research & Early Dev.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Common Stock, $0.10 par value | SSaleDisposed | −6,198 | $61.99 | −$384,214.02 | 45,060 | Direct | |
| Dec 16, 2021 | Common Stock, $0.10 par value | SSaleDisposed | −13,100 | $61.99 | −$812,069 | 31,960 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.